256 related articles for article (PubMed ID: 21779318)
1. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.
Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Arias-Carrión O; Drucker-Colín R
PLoS One; 2011; 6(7):e20766. PubMed ID: 21779318
[TBL] [Abstract][Full Text] [Related]
2. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
3. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
4. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
[TBL] [Abstract][Full Text] [Related]
6. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
Ho WS; Barrett DA; Randall MD
Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
[TBL] [Abstract][Full Text] [Related]
9. In vivo brain levels of acetylcholine and 5-hydroxytryptamine after oleoylethanolamide or palmitoylethanolamide administrations are mediated by PPARα engagement.
Murillo-Rodríguez E; Arankowsky-Sandoval G; Budde H; Imperatori C; Machado S; Yamamoto T; Yadollahpour A; Torterolo P
Eur J Neurosci; 2021 Sep; 54(6):5932-5950. PubMed ID: 34396611
[TBL] [Abstract][Full Text] [Related]
10. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats.
Murillo-Rodríguez E; Millán-Aldaco D; Palomero-Rivero M; Mechoulam R; Drucker-Colín R
FEBS Lett; 2006 Aug; 580(18):4337-45. PubMed ID: 16844117
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice.
Lenglet S; Thomas A; Soehnlein O; Montecucco F; Burger F; Pelli G; Galan K; Cravatt B; Staub C; Steffens S
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):215-23. PubMed ID: 23241405
[TBL] [Abstract][Full Text] [Related]
13. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of FAAH confers increased stem cell migration via PPARα.
Wollank Y; Ramer R; Ivanov I; Salamon A; Peters K; Hinz B
J Lipid Res; 2015 Oct; 56(10):1947-60. PubMed ID: 26263913
[TBL] [Abstract][Full Text] [Related]
15. Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation.
Soria-Gómez E; Guzmán K; Pech-Rueda O; Montes-Rodríguez CJ; Cisneros M; Prospéro-García O
Pharmacol Res; 2010 May; 61(5):379-84. PubMed ID: 20100574
[TBL] [Abstract][Full Text] [Related]
16. The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.
Hamtiaux L; Masquelier J; Muccioli GG; Bouzin C; Feron O; Gallez B; Lambert DM
BMC Cancer; 2012 Mar; 12():92. PubMed ID: 22429826
[TBL] [Abstract][Full Text] [Related]
17. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
Murillo-Rodríguez E; Machado S; Rocha NB; Budde H; Yuan TF; Arias-Carrión O
Neuroscience; 2016 Dec; 339():433-449. PubMed ID: 27746343
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of CaMKII in the rat dorsal raphe nucleus plays an important role in sleep-wake regulation.
Cui SY; Li SJ; Cui XY; Zhang XQ; Yu B; Sheng ZF; Huang YL; Cao Q; Xu YP; Lin ZG; Yang G; Song JZ; Ding H; Wang ZJ; Zhang YH
J Neurochem; 2016 Feb; 136(3):609-19. PubMed ID: 26558357
[TBL] [Abstract][Full Text] [Related]
19. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
Hansen HS
Exp Neurol; 2010 Jul; 224(1):48-55. PubMed ID: 20353771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
